血管内皮生长因子与抑郁症关系的临床研究进展
被引量:2
摘要
抑郁症是精神障碍中常见的一种疾病,其终生患病率约10%.自杀率高达15%:神经营养假说认为,脑内神经营养因子的不足会对神经系统的结构或功能造成影响,血管内皮生长因子(vascular endothelial growth factor,VEGF)是一种重要的神经营养因子,相对分子量34~45kDa,主要由神经细胞、神经胶质细胞及炎症细胞产生,具有促进神经细胞生长、保护神经细胞、增强突触可塑性等作用,并有望成为治疗抑郁症的新分子靶点。
出处
《浙江医学》
CAS
2015年第10期901-903,共3页
Zhejiang Medical Journal
基金
浙江省医药卫生一般研究项目(2011KYB098)
参考文献29
-
1Howell K R, Kutiyanawalla A, Pillai A, et al. Long-term continuous corticosterone treatment decreases VEGF receptor-2 expression in frontal cortex[J]. PLoS One, 2011,6(5): e20198.
-
2Galecki P, Orzechowska A, Berent D, et al. Vascular endothelial growth factor receptor 2 gene(KDR) polymorphisms and expres- sion levels in depressive disorder[J]. J Affect Disord, 2013, 147 (1-3): 144-149.
-
3Berent D, Macander M, Szemraj J, et al. Vascular endothelial growth factor A gene expression level is higher in patients with major depressive disorder and not affected by cigarette smoking, hyperlipidemia or treatment with statins[J]. Acta Neurobiol Exp (Wars), 2014, 74(1): 82-90.
-
4Clark-Raymond A, Meresh E,Hoppensteadt D, et al.Vascular En-dothelial Growth Factor: A potential diagnostic biomarker for ma- jor depression[J]. J Psychiatr Res, 2014,59:22.
-
5Effving B, Buttenschon H N, Foldager L, et al.Depression and BML influences the serum vascular endothelial growth factor level[J]. I nt J Neuropsychopharmacol, 2014,17(9): 1409-1417.
-
6Lee B H, Kim Y K. Increased plasma VEGF levels in major de- pressive or manic episodes in patients with mood disorders[J]. J Affect Disord, 2012,136(1-2): 181-184.
-
7Kotan Z, Sarandol E, Kirhan E, et al. Serum brain-derived neu- rotrophic factor, vascular endothelial growth factor and leptin lev- els in patients with a diagnosis of severe major depressive disor- der with melancholic features[J]. Ther Adv Psychopharmacol, 2012, 2(2): 65-74.
-
8Isung J, Mobarrez F, Nordstrom P, et al. Low plasma vascular endothelial growth factor(VEGF) associated with completed sui- cide[J]. World J Biol Psychiatry, 2012, 13(6): 468-473.
-
9Clark-Raymond A, Halaris A. VEGF and depression: a compre- hensive assessment of clinical data[J]. J Psychiatr Res, 2013, 47 (8): 1080-1087.
-
10Murphy B P, Pang T Y, Hannan A J, et al. Vascular endothelial growth factor and brain-derived neurotrophic factor in quetiap- ine treated first-episode psychosis[J]. Schizophr Res Treat- ment, 2014, 2014: 719395.
二级参考文献34
-
1孙学礼.难治性抑郁障碍及其药物治疗[J].中国处方药,2006(10):9-13. 被引量:10
-
2Plouet J, Moro F, Bertagnolli S, et al. Extracellular cleavage of the vascular endothelial growth factor189 - amino acid form by u- rokinase is required for its mitogenic effect [ J 3. J Biol Chem, 1997, 272(20) : 13390 - 13396.
-
3Greenberg DA, Jin K. Experiencing VEGF [ J ]. Nat Genet, 2004, 36(8) :792 -793.
-
4Schanzer A, Wachs FP, Wilhelm D, et al. Directstimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascularendo- thelial growth factor[ J ]. Brain Patho1,2004,14(3 ) :237 - 248.
-
5Storkebaum E, Lambrechts D, Carmeliet P. VEGF : once regarded as a specific angiogenicfactor, now implicated in neuroprotection [ J ]. Bioessays,2004,26 (9) :943 - 954.
-
6Warner - Schmidt JL, Duman RS. VEGF as a potential target for therapeutic intervention in depression [ J ]. Curr Opin Pharmacol, 2008,8(1) :14 -19.
-
7Kosel M, Berney A. Treatment resistant depression: therapy and novel neuromodulatory treatments [ J ]. Rev Med Suisse, 2012,8 (339) :942 -945.
-
8Zheng YP, Zhao JP, Phillips M, et al. Validity and reliability of the Chinese Hamilton Depression Rating Scale [ J]. Br J Psychia- try, 1988,152:660 - 664.
-
9Minelli A, Zanardini R, Abate M, et al. Vascular Endothelial Growth Factor (VEGF) serum concentration during electroconvulsive therapy (ECT) in treatment resistant depressed patients[J]. Prog Neuropsy- chopharmacol Bid Psychiatry ,2011,35 (5) : 1322 - 1325.
-
10Sen S, Duman R, Sanacora G. Serum brain - derived neurotrophic factor, depression, and antidepressant medications: meta- analyses and implications [ J ]. Biol Psychiatry, 2008,64 ( 6 ) : 527 - 532.
共引文献4
-
1张庆玉,朱珍珍,付建飞,季蕴辛,刘雅辉,杨璐,邬丹娟,王训强,楼忠泽,阮列敏.复发性抑郁症患者治疗前后血管内皮生长因子水平变化及与临床疗效的相关性[J].浙江医学,2016,38(4):252-255. 被引量:6
-
2唐咏春,周喜燕,高丽丽.针灸疗法对急性脑梗死后抑郁患者临床疗效及血清VEGF水平的影响研究[J].当代医学,2017,23(12):25-27. 被引量:4
-
3黄祖秀,周荣,陈妙,林书阳,吴志敏,朱敬滨,项祖闯.柴胡桂枝干姜汤加减治疗偏头痛伴焦虑状态的临床疗效观察及对血清VEGF、5-HT的影响[J].中国中医药科技,2022,29(5):737-741. 被引量:3
-
4吉荣图,郑兰兵.MECT与抑郁患者VEGF表达间相关性研究进展[J].临床医学进展,2024,14(7):1275-1283.
同被引文献24
-
1陶然,赵卫红,秦博宇,焦顺昌.年轻女性乳腺癌潜在核心基因的生物信息学分析[J].解放军医学院学报,2020(4):393-398. 被引量:1
-
2刘新发,韩亚光.抑郁与癌症研究进展[J].广东医学,2006,27(8):1266-1268. 被引量:11
-
3邹吉林,周仁来.人类情绪记忆的行为与神经遗传学研究进展述评[J].心理科学,2013,36(4):1004-1008. 被引量:2
-
4张松峰,田华,潘立新.老年乳腺癌患者复发类型及其危险因素[J].中国老年学杂志,2013,33(19):4722-4724. 被引量:11
-
5苏永强,邓述恺.血管内皮生长因子及受体在肿瘤发病机制中的研究进展[J].现代医药卫生,2014,30(2):235-237. 被引量:5
-
6苑杰,严辞,刘昊,王海涛,杨美荣,王静.抑郁症生物标志物研究进展[J].国际精神病学杂志,2015,42(2):103-107. 被引量:33
-
7孟醒,范姝雅,王鹏宇,马宁.乳腺癌抑郁中医证候系统综述[J].实用中医内科杂志,2015,0(11):4-6. 被引量:6
-
8郭晓杰,田峰.抑郁症患者认知功能及相关影响因素研究进展[J].中国药物与临床,2016,16(3):368-370. 被引量:8
-
9孙士玲,杨丽萍,张红瑞,吴耀松.逍遥散加味对乳腺癌术后化疗患者抑郁症的影响[J].中华中医药杂志,2016,31(4):1499-1502. 被引量:22
-
10冯建伟,郑伟,周舒颖,唐利荣,张艳芳,向应强.预防抑郁症患者疾病复发的研究现况[J].神经疾病与精神卫生,2016,0(2):209-212. 被引量:15
引证文献2
-
1李丹云,蓝婉宁,袁泽焕,廖秋华,陈彦彤,郑锦湖,曹阳.乳腺癌-抑郁症关联基因筛选与中药预测的生物信息学研究[J].广西医学,2023,45(15):1856-1863. 被引量:2
-
2化继红.护士抑郁症认知状况的调查分析[J].世界最新医学信息文摘,2016,0(98):170-170.
-
1张鹏,王剑,周全,陈颖,朱明华.神经生长因子与胰腺癌的临床研究进展[J].国际病理科学与临床杂志,2009,29(6):529-531. 被引量:1
-
2吴有盛,路凡,齐颖新,王瑞华,张剑,卢兹凡,赵忠良.Restin与转录因子的相互作用[J].中国科学(C辑),2004,34(5):459-464. 被引量:3
-
3徐秀平,董学君.神经导向因子4与肿瘤[J].中华临床实验室管理电子杂志,2015,3(2):92-95.
-
4梁博,王鹤令.色素上皮衍生因子(PEDF)抗肿瘤作用研究进展[J].现代肿瘤医学,2012,20(9):1990-1992.
-
5余明华(综述),韩建群(综述),修瑞娟(审校).色素上皮衍生因子的抗肿瘤潜能[J].国际肿瘤学杂志,2007,34(8):569-573.
-
6冯灵美,蔡季平.Neuregulin-1在神经元变性中的研究进展[J].实用医学杂志,2009,25(12):2093-2094.
-
7杨勇,彭浩,陈超波,虞浩,张志坚,龚爱华,王存祖,陈永昌.神经生长因子及其受体在人脑胶质瘤细胞株U251中的表达及其生物学意义[J].中国临床康复,2006,10(38):94-96. 被引量:7
-
8董漪,董强.血管内皮生长因子与卒中及神经系统退行性疾病[J].中国卒中杂志,2009,4(2):152-158. 被引量:4
-
9江艳,任明山.血管内皮生长因子与脑梗死[J].安徽医药,2009,13(6):585-587. 被引量:1
-
10邵欣,曾芳,余曙光.神经细胞粘附分子与老年性痴呆突触可塑性研究进展[J].四川生理科学杂志,2006,28(3):118-121. 被引量:3